Transitional Year·Blacksburg, VA

HCA Healthcare LewisGale Hospital-Montgomery/VCOM

Signal lift20%49%+29 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
239–269
p10 – p90
Sample N
356
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
1.7%
6 of 356 applicants
01Cohort funnelthis cycle
N = 356
Applied
356
100.0%
Invited
46
12.9%
Class size
6
1.7%
No visa sponsorshipGraduated within 2 yearsPreliminaryHospitalistWomen's Health
Your fitHCA Healthcare LewisGale Hospital-Montgomery/VCOM Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at HCA Healthcare LewisGale Hospital-Montgomery

Create free account

Who to contact

Training sites3 hospitals · Blacksburg
  • 1
    HCA Healthcare LewisGale Hospital-Montgomery/VCOM
    Blacksburg, VA
    Primary
  • 2
    Veterans Affairs Medical Center (Salem)
    Salem, VA
    Participant
  • 3
    LewisGale Hospital-Montgomery
    Blacksburg, VA
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK239 – 269
180205230255280

Level 2 CE data not available

Interview rates
US MD
18%
US DO
11%
US IMG
4%
Non-US IMG
0%
Applicant origin
In-state
43%
Out-of-state
10%
Interview prepTransitional Year
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add HCA Healthcare LewisGale Hospital-Montgomery/VCOM to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Transitional Year.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.